remdesivir

Backorders, complaints over low supply started moderating in the second week of May, says drugmaker

A World Health Organisation-led trial found in October that it failed to improve Covid-19 survival rates

Manufacturer Gilead questions Solidarity Trial’s results, says it was disappointed at the new WHO guideline

Olumiant is an oral medication used to treat moderately-to-severely active rheumatoid arthritis

Remdesivir is the first and only drug approved in United States for treating patients with Covid-19

A WHO-led trial is looking at the potential effect of Gilead’s antiviral drug remdesivir on Covid-19

Allows tax-free import of 60 other tools used in treatment of Covid-19 until Sept 30

Many scientists believe antibody based therapies hold great promise for treating infected people

Gilead’s shares jumped nearly 10% following a media report detailing encouraging partial data from trials

Searle Company Limited has entered into an exclusive licensing, marketing agreement with Beximco Pharmaceuticals

Rush to develop Covid-19 vaccine drives up prices for pharmaceutical stocks

US firm has entered licensing agreement with Ferozsons Laboratories, four Indian manufacturers to produce Remdesivir

Remdesivir was earlier found effective against the infection during an international drug trial

Gilead had said the drug helped improve outcomes for patients with coronavirus

A US study published this week raised great hope for the effectiveness of the antiviral drug remdesivir

It represents the first time any medication has been shown to improve outcomes against the Covid-19 illness

Trial was stopped early because of side-effects, says WHO

Patients showed signs of improvement despite having severe fever and respiratory problems